bridging loan

Genomic Vision Announces the Convening of an Extraordinary Shareholders' Meeting on February 15, 2019, and Provides an Update on Its Financial Situation – Business Wire

Leave a comment

Genomic Vision Announces the Convening of an Extraordinary Shareholders’ Meeting on February 15, 2019, and Provides an Update on Its Financial Situation  Business Wire

Regulatory News: Genomic Vision (Paris:GV) (FR0011799907 – GV), a company specialized in the development of in-vitro diagnostic (IVD) tests for the ea.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.